Clinical trial for Huntington Disease
Official title Early Biomarkers in Premanifest Huntington's Disease Gene Carriers: a Pilot Study
ClinicalTrials.gov ID: NCT06626308
What this study is testing
- What it's testing
- The study wants to see if new brain scans or virtual‑reality walking tests can find early signs of Huntington’s disease in people who carry the gene but are still healthy.
- Who it's for
- It looks for adults who carry the Huntington’s disease gene but do not yet show symptoms.
- What's involved
- Participants will have a functional brain MRI and a virtual‑reality gait test, and will also be compared to healthy people who do not carry the gene.
- Time commitment
- The study involves a few visits for the MRI and gait test, lasting a few hours in total.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- 1\. For PMGC: HD diagnosis confirmed by genetic testing (CAG triplets ≥36 in HTT gene)
You likely can't join if
- Main exclusion criteria for both PMGC and HS will be: major ophthalmologic and psychiatric active diseases
The study team makes the final eligibility decision.
Where it is enrolling
- Grenoble, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Grenoble, France. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.